Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CPVL antisense RNA 1 (CPVL-AS1)
- Target
- CPVL-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA
01
Overview
CPVL antisense RNA 1 (CPVL-AS1) is a long non-coding RNA transcribed from the opposite strand of the CPVL gene on chromosome 7. As an antisense RNA, CPVL-AS1 is part of a class of non-coding RNAs that regulate gene expression by base-pairing with their corresponding sense transcripts, thereby modulating transcription, mRNA stability, or epigenetic state. While antisense RNAs are recognized as important regulators of gene expression in both prokaryotes and eukaryotes, there is currently no evidence that CPVL-AS1 serves as a receptive or catalytic therapeutic target, nor is there data linking it directly to specific diseases or drug interactions. The principal function of such antisense transcripts is believed to be the fine-tuning of gene activity, often in a tissue-specific manner, but additional research is needed to clarify the precise roles and potential clinical relevance of CPVL-AS1.
- Other names
- CPVL-AS1
02
Biological functions
Regulation of gene expression, typically by modulating transcription of the sense gene (here, likely CPVL)May play a role in posttranscriptional modulation or local epigenetic regulation
Beyond the preview
Go deeper on CPVL antisense RNA 1 (CPVL-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CPVL antisense RNA 1 (CPVL-AS1).